Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Aug 8;49(11):4697–4701. doi: 10.1167/iovs.08-2324

Table 2.

Representative uveal melanoma cell line karyotpic profiles

Cell Line Comments Karyotype
C918 Cells as received from the donor laboratory, passage 10 46,X,-?,inv(5)(p15q33),
der(7;17)(p10;q10),del(10)(q22q24),
der(13;?16)(q10;q10), der(18)t(9;18)(q?31;q22),+add(21)(p11.2),del(22)(q12),+del(22)(q12)[9]
C918 Cells in our laboratory, passage 10 47,X,-?,+del(3)(p13),inv(5)(p15q33),
der(7;17)(p10;q10),i(8)(q10),del(10)(q22q24),
der(13;?16)(q10;q10),der(18)t(9;18)(q?31;q22), +add(21)(p11.2),del(22)(q12),+del(22)(q12)[10]
M619 Cells received from contributing laboratory, passage 5 82~91<4n>,XX,-?,-?,+del(3)(p13),-4,inv(5)(p15q33)x2,
der(7;17)(p10;q10)x2,i(8)(q10)x2,-9, del(10)(q22q24)x2,del(12)(q13q2?4.1)x2,
der(1 3;?16)(q10;q10)x2,add(14)(p13)x2,-16,
der(18)t(12;18)(q13;q22)x2,+add(21)(p11.2)x2, -22x2,+2~5mar[10]
M619 Cells in our laboratory, passage 10 80~88<4n>,X,-X,-?,-?,add(2)(q3?7),-4,inv(5)(p15q33)x2,
der(7;17)(p10;q10)x2,i(8)(q10),+i(8)(q10), del(10)(q22q24)x2,
der(11)t(11;15)(p13;q11.2),
der(13;?16)(q10;q10)x2,-16, der(14)t(7;14)(p13;p11.2),-15,
der(18)t(12;18)(q13;q22)x2,+add(21)(p11.2) x2,-22x2,+1~5mar[11]